BioCentury
ARTICLE | Company News

Amneal Pharmaceuticals, Hanmi Pharmaceutical, AstraZeneca sales and marketing update

January 13, 2014 8:00 AM UTC

Amneal launched in the U.S. an authorized generic of AstraZeneca's gastrointestinal drug Nexium esomeprazole strontium delayed-release capsules. Amneal said it cannot comment on pricing because the company sells esomeprazole strontium delayed-release capsules through wholesalers. Late last year, the company launched a generic esomeprazole from Hanmi in the U.S. In 2012, Amneal acquired exclusive rights to Hanmi's NDA for the delayed-release capsules. Last month, the U.S. Court of Appeals for the Federal Circuit ruled that Hanmi's generic version of AstraZeneca's Nexium esomeprazole does not infringe on the pharma's U.S. Patent No. 5,714,504 (see BioCentury, Jan. 6). ...